Your browser is no longer supported. Please, upgrade your browser.
Settings
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E83.32 EPS (ttm)3.10 Insider Own0.20% Shs Outstand272.01M Perf Week7.07%
Market Cap73.87B Forward P/E20.72 EPS next Y12.48 Insider Trans-17.17% Shs Float271.07M Perf Month8.99%
Income853.00M PEG16.66 EPS next Q2.09 Inst Own83.60% Short Float0.79% Perf Quarter3.44%
Sales17.41B P/S4.24 EPS this Y24.40% Inst Trans1.25% Short Ratio0.99 Perf Half Y-5.41%
Book/sh77.01 P/B3.36 EPS next Y19.84% ROA1.80% Target Price274.43 Perf Year2.03%
Cash/sh8.25 P/C31.34 EPS next 5Y5.00% ROE4.40% 52W Range197.75 - 286.72 Perf YTD-4.91%
Dividend3.16 P/FCF39.38 EPS past 5Y-8.90% ROI4.30% 52W High-10.44% Beta0.93
Dividend %1.22% Quick Ratio0.70 Sales past 5Y15.40% Gross Margin46.50% 52W Low29.86% ATR6.41
Employees70093 Current Ratio1.00 Sales Q/Q1.40% Oper. Margin9.20% RSI (14)63.27 Volatility2.29% 2.51%
OptionableYes Debt/Eq1.01 EPS Q/Q390.40% Profit Margin5.30% Rel Volume0.25 Prev Close258.61
ShortableYes LT Debt/Eq0.80 EarningsAug 06 BMO Payout91.50% Avg Volume2.18M Price256.80
Recom2.10 SMA207.38% SMA504.56% SMA2001.97% Volume409,656 Change-0.70%
Jul-09-20Upgrade Barclays Equal Weight → Overweight $300
Jun-01-20Resumed Goldman Buy $278
Mar-05-20Initiated Citigroup Neutral $260
Feb-07-20Downgrade Raymond James Strong Buy → Outperform $283
Feb-07-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20Downgrade Cowen Outperform → Market Perform
Feb-06-20Downgrade Cowen Outperform → Market Perform
Jan-08-20Downgrade Barclays Overweight → Equal Weight $275
May-13-19Upgrade Barclays Equal Weight → Overweight $266
Dec-07-18Initiated Deutsche Bank Buy $280
Oct-16-18Initiated Barclays Equal Weight $278
Jun-21-18Upgrade JP Morgan Neutral → Overweight
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Jan-03-18Initiated Evercore ISI Outperform
Dec-29-17Reiterated Deutsche Bank Buy $239 → $260
Nov-03-17Reiterated RBC Capital Mkts Sector Perform $210 → $230
Sep-22-17Initiated Wells Fargo Outperform $225
Jul-08-20 12:25PM  
08:41AM  
08:39AM  
07:44AM  
07:15AM  
06:59AM  
Jul-07-20 08:57PM  
04:21PM  
09:35AM  
08:08AM  
06:59AM  
Jul-06-20 06:42PM  
04:39PM  
04:15PM  
04:03PM  
03:39PM  
10:53AM  
07:43AM  
07:07AM  
07:00AM  
06:59AM  
Jul-03-20 03:00AM  
Jul-02-20 04:10PM  
Jun-19-20 09:47AM  
Jun-06-20 11:31AM  
Jun-04-20 03:20PM  
Jun-01-20 05:00PM  
May-27-20 06:11PM  
01:25PM  
12:56PM  
08:00AM  
May-26-20 04:15PM  
06:11AM  
May-21-20 02:06AM  
May-20-20 03:33PM  
May-19-20 04:05PM  
May-18-20 04:20PM  
01:38PM  
May-16-20 09:15AM  
May-15-20 06:40AM  
May-14-20 06:43AM  
May-13-20 06:23AM  
May-11-20 10:34AM  
May-10-20 12:43PM  
May-07-20 10:30PM  
11:20AM  
09:09AM  
07:35AM  
May-06-20 09:07AM  
May-04-20 11:02AM  
09:03AM  
May-03-20 08:26PM  
Apr-30-20 06:45PM  
12:34PM  
Apr-29-20 07:10AM  
06:40AM  
Apr-28-20 07:00AM  
Apr-27-20 12:55PM  
11:45AM  
10:57AM  
10:33AM  
09:30AM  
09:00AM  
08:28AM  
Apr-26-20 10:50PM  
02:45PM  
01:45PM  
01:00PM  
11:15AM  
Apr-25-20 02:45PM  
01:00PM  
11:04AM  
Apr-24-20 10:50PM  
08:05PM  
05:45PM  
05:10PM  
03:22PM  
01:15PM  
12:31PM  
11:44AM  
11:30AM  
11:00AM  
10:56AM  
10:18AM  
02:55AM  
Apr-23-20 06:00PM  
02:01PM  
12:30PM  
12:00PM  
11:00AM  
10:57AM  
09:34AM  
Apr-22-20 10:50PM  
08:44PM  
04:55PM  
04:10PM  
02:20PM  
12:36PM  
10:45AM  
10:00AM  
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaltenbach PatrickEVP & Pres Life SciencesJun 05Sale243.201,049255,11711,612Jun 05 03:07 PM
Kaltenbach PatrickEVP & Pres Life SciencesJun 02Sale244.8322254,35214,688Jun 02 02:24 PM
Fraser ClaireDirectorMay 08Sale256.56771197,80820,168May 08 02:29 PM
Khichi Samrat S.EVP and General CounselMar 16Sale224.534,349976,4815,262Mar 17 01:03 PM
Fraser ClaireDirectorFeb 11Sale258.721,500388,07420,939Feb 11 03:17 PM
Campion Simon DEVP and Segment PresidentFeb 04Option Exercise115.6813,6121,574,62115,556Feb 05 02:48 PM
Campion Simon DEVP and Segment PresidentFeb 04Sale285.098,0852,304,95310,773Feb 05 02:48 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesFeb 04Sale285.001,430407,5508,381Feb 05 09:13 AM
FORLENZA VINCENT AChairman, CEO and PresidentJan 28Option Exercise72.1238,3622,766,667247,226Jan 28 05:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 28Sale280.9628,5148,011,293208,864Jan 28 05:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 27Option Exercise72.1234,4062,481,361243,270Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 27Sale280.0925,5467,155,179208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 24Option Exercise72.129,666697,112218,530Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 24Sale280.137,1772,010,493208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 23Option Exercise72.128,464610,424217,328Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 23Sale280.066,2841,759,897208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 10Option Exercise72.1226,6651,923,080235,529Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 10Sale275.1519,6755,413,576208,864Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 08Option Exercise72.1218,7831,354,630227,647Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 08Sale275.1913,8603,814,133208,864Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 02Option Exercise72.1245,4483,277,710254,312Jan 03 09:08 AM
FORLENZA VINCENT AChairman, CEO and PresidentJan 02Sale271.2833,3659,051,257208,864Jan 03 09:08 AM
Polen Thomas E JrExecutive Vice PresidentDec 16Option Exercise145.8013,9072,027,59027,117Dec 17 11:39 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesDec 16Option Exercise134.7312,1531,637,37427,739Dec 18 09:45 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesDec 16Sale269.5111,8603,196,3899,811Dec 18 09:45 AM
Polen Thomas E JrExecutive Vice PresidentDec 16Sale269.636,3861,721,85717,117Dec 17 11:39 AM
Spoerel Thomas JVP Controller & Chief Acct OffDec 13Sale267.95506135,5831,035Dec 16 09:10 AM
FORLENZA VINCENT AChairman, CEO and PresidentDec 12Option Exercise76.6416,3431,252,528225,393Dec 16 09:15 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 12Option Exercise242.104,2361,025,53619,546Dec 16 09:17 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 12Sale263.2333989,23515,310Dec 16 09:17 AM
FORLENZA VINCENT AChairman, CEO and PresidentDec 12Sale265.5711,6263,087,517209,050Dec 16 09:15 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 06Sale261.5131281,59115,310Dec 06 04:11 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeSep 06Option Exercise134.733,143423,4565,180Sep 09 01:19 PM
Polen Thomas E JrExecutive Vice PresidentSep 06Option Exercise150.1213,7602,065,65130,215Sep 09 01:50 PM
Lim James CExecutive Vice PresidentSep 06Option Exercise108.8915,8481,725,68933,041Sep 09 10:55 AM
FORLENZA VINCENT AChairman, CEO and PresidentSep 06Option Exercise76.6416,3431,252,528237,431Sep 10 10:50 AM
FORLENZA VINCENT AChairman, CEO and PresidentSep 06Sale260.3811,5323,002,702221,088Sep 10 10:50 AM
Lim James CExecutive Vice PresidentSep 06Sale263.539,2992,450,56517,193Sep 09 10:55 AM
Polen Thomas E JrExecutive Vice PresidentSep 06Sale260.265,8231,515,49416,455Sep 09 01:50 PM
Bodner Charles RSVP Corp Fin Chief Acct OfficeSep 06Sale260.081,514393,7612,037Sep 09 01:19 PM
Conroy AlexandreEVP of Integrated Supply ChainAug 30Sale256.724611,80916,489Sep 03 09:47 AM
Conroy AlexandreEVP of Integrated Supply ChainAug 29Sale255.069,8292,506,98516,535Aug 29 04:39 PM
Lim James CExecutive Vice PresidentAug 09Option Exercise75.2133,9662,554,73139,902Aug 12 11:21 AM
Lim James CExecutive Vice PresidentAug 09Sale253.3123,8796,048,78917,193Aug 12 11:21 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 09Sale253.7812732,23015,930Aug 12 09:57 AM
Goette RolandEVP and President, EMEAAug 08Option Exercise75.632,463186,2778,710Aug 09 10:49 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 08Option Exercise224.942,865644,45319,072Aug 09 11:11 AM
Lim James CExecutive Vice PresidentAug 08Option Exercise76.642,773212,52319,966Aug 09 10:09 AM
Lim James CExecutive Vice PresidentAug 08Sale252.011,929486,12717,193Aug 09 10:09 AM
Kaltenbach PatrickEVP & Pres Life SciencesAug 08Sale246.5540098,62016,057Aug 09 11:11 AM
Goette RolandEVP and President, EMEAAug 08Sale249.881,717429,0446,247Aug 09 10:49 AM
Fraser ClaireDirectorAug 07Sale243.261,429347,61921,544Aug 07 02:56 PM